NEW YORK (GenomeWeb) – Luminex announced before the opening of the market on Monday that it expects to report fourth quarter revenues of $72 million, and 2016 revenue of $271 million, beating the average analyst estimates of $70.3 million and $268.9 million, respectively.

The preliminary revenues were up 20 percent in Q4 and 14 percent in 2016 over the prior-year periods.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.